Files

T

Fabio 5941153bb7 Legislation: batch B — IL IN KS KY LA MA MD ME MI MN

Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>

2026-07-06 17:27:20 -04:00

4.6 KiB

Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type

title

description

jurisdiction

legislature

session

identifier

citation

classification

subjects

status

primary_sponsors

version_count

action_count

vote_count

first_action

last_action

source

source_identifier

source_url

source_hash

vintage

source_snapshot

retrieved_at

confidence

Louisiana HB 629 (2023) — TAX/SALES-USE, LOCAL-EXEM: Exempts from local sales and use taxes certain prescription drugs administered by topical system in medical clinics (EN DECREASE LF RV See Note)

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

HB629 Original (filed) — source
HB629 Act (committee substitute) — source
HB629 Engrossed (committee substitute) — source
Senate Committee Amendment, #1986, R&F, Draft (committee substitute) — source
Senate Committee Amendment, #2004, R&F, Adopted (committee substitute) — source
HB629 Enrolled (enrolled) — source

Votes

CONCUR IN SENATE AMENDMENTS (#1104) — 98–1 (pass) · lower
FINAL PASSAGE (#481) — 95–2 (pass) · lower
FINAL PASSAGE (#754) — 37–0 (pass) · upper

Timeline

The legislative action history — every referral, reading, and vote.

2023-06-14 Effective date: 07/01/2023.
2023-06-14 Signed by the Governor. Becomes Act No. 382. became-law, executive-signature
2023-06-09 Sent to the Governor for executive approval. executive-receipt
2023-06-08 Signed by the President of the Senate.
2023-06-07 Enrolled and signed by the Speaker of the House. enrolled
2023-06-06 Read by title, roll called, yeas 98, nays 1, Senate amendments concurred in.
2023-06-05 Scheduled for concurrence on 06/06/2023.
2023-06-05 Received from the Senate with amendments. receipt
2023-06-04 Rules suspended. The amended bill was read by title, passed by a vote of 37 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled. passage
2023-05-24 Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage. reading-3
2023-05-23 Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.
2023-05-22 Reported with amendments. committee-passage-favorable
2023-05-18 Read second time by title and referred to the Committee on Revenue and Fiscal Affairs. reading-2, referral-committee
2023-05-17 Received in the Senate. Rules suspended. Read first time by title and placed on the Calendar for a second reading. reading-1
2023-05-17 Read third time by title, roll called on final passage, yeas 95, nays 2. Finally passed, title adopted, ordered to the Senate. passage
2023-05-11 Scheduled for floor debate on 05/17/2023.
2023-05-09 Read by title, ordered engrossed, passed to 3rd reading. reading-3
2023-05-08 Reported favorably (12-0). committee-passage-favorable
2023-04-20 Read by title, under the rules, referred to the Committee on Ways and Means. referral-committee
2023-04-19 Read by title. Lies over under the rules.

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/257a48df-a29f-4d53-a6fa-170b87e27eba. Confidence: reported (aggregated from official Louisiana legislature records).

4.6 KiB Raw Permalink Blame History Unescape Escape